🔎 Trials Near Me

Akèy › Maladi Alzheimer › Kalifòni › Los Angeles

Etid klinik pou Maladi Alzheimer nan Los Angeles, CA

14 etid pou Maladi Alzheimer ap chèche patisipan nan sit nan ak bò kote Los Angeles (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of LY3439539 in Participants With Alzheimer's Disease

Ap rekriteFaz 1
  • Inglewood Clinical, Los Angeles
Laj 50 a 85 · Tout sèks · Mizajou Sep 24, 2026 · NCT07598370

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

Ap rekriteFaz 3
  • USC - The Memory and Aging Center (MAC) - Alzheimer Disease Research Center (ADRC), Los Angeles
Laj 55 a 90 · Tout sèks · Mizajou Sep 22, 2026 · NCT06585787

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

Ap rekriteFaz 3
  • Inglewood Clinicals, Los Angeles
Laj 50 a 90 · Tout sèks · Mizajou Sep 21, 2026 · NCT07177352

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

Ap rekriteFaz 3
  • Inglewood Clinical, Los Angeles
Laj 60 a 85 · Tout sèks · Mizajou Sep 17, 2026 · NCT06976203

Large-coil Parietal Repetitive Transcranial Magnetic Stimulation (rTMS) for Alzheimer Disease (AD)

Ap rekriteFaz 1/2
  • UCLA TMS Clinical and Research Service, Los Angeles
Laj 55 a 100 · Tout sèks · Mizajou Sep 4, 2026 · NCT06597942

A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)

Ap rekriteFaz 2
  • Inglewood Clinical ( Site 1062), Los Angeles
Laj 50 a 85 · Tout sèks · Mizajou Aug 26, 2026 · NCT07033494

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

Ap rekriteFaz 3
  • University of California, Los Angeles (UCLA) - David Geffen School of Medicine, Los Angeles
Laj 18 a 75 · Tout sèks · Mizajou Aug 4, 2026 · NCT06563895

A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

Ap rekriteFaz 2/3Volontè an sante akeyi
  • University of Southern Califonria, Los Angeles
Laj 18 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT05552157

A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

Ap rekriteFaz 2/3Volontè an sante akeyi
  • University of Southern Califonria, Los Angeles
Laj 18 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT06647498

A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease

Ap rekriteFaz 2
  • University of California at Los Angeles, Los Angeles
Laj 50 a 85 · Tout sèks · Mizajou Jun 26, 2026 · NCT07094516

Polyphenols and Cognitive Decline

Ap rekriteVolontè an sante akeyi
  • University of California, Los Angeles, Los Angeles
Laj 50 ak plis · Tout sèks · Mizajou Jun 11, 2026 · NCT06507254

[18F]PI-2620 Phase 3 Histopathological Study

Ap rekriteFaz 3
  • UC Los Angeles, Los Angeles
Laj 50 ak plis · Tout sèks · Mizajou May 22, 2026 · NCT05641688

Cardiac-Control Affecting Learning Through Mindfulness (CALM)

Ap rekriteVolontè an sante akeyi
  • University of Southern California, Los Angeles
Laj 50 a 70 · Tout sèks · Mizajou May 13, 2026 · NCT06410157

Transcranial Photobiomodulation (tPBM) in Alzheimer's Disease Study

Ap rekrite
  • CSMC, Los Angeles
Laj 55 a 89 · Tout sèks · Mizajou Nov 19, 2025 · NCT07224607

Etid Maladi Alzheimer nan lòt vil

Lòt etid nan Los Angeles

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.